The average milk to plasma ratio was 0.20. Nurtec ODT has not been studied in patients with end-stage renal disease (ESRD) and in patients on dialysis; avoid use in patients with ESRD. No dosage ...

That compares pretty well with the oral CGRPs – around 20% of Nurtec ODT patients were pain-free at two hours in its phase 3 trials – but some commentators have questioned whether the ...

so that we can continue to focus on the needs of patients," Pfizer said in a statement to Reuters. Pfizer paid $11.6bn to buy Biohaven, largely on the financial performance of Nurtec ODT.